Xiaofei Li
Impact in
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Gastric Cancer Management and Outcomes
- Oncology top 10%
- Lung Cancer Research Studies
- Colorectal Cancer Surgical Treatments
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Lung Cancer Treatments and Mutations 16
- Lung Cancer Diagnosis and Treatment 7
- Gastric Cancer Management and Outcomes 4
- Sarcoma Diagnosis and Treatment 2
- Oncology 15
- Lung Cancer Research Studies 8
- Co-authors
- Chun Chen (5 shared papers)Weimin Mao (5 shared papers)Lanjun Zhang (4 shared papers)Yi Shen (4 shared papers)Qun Wang (3 shared papers)Dongsheng Yue (3 shared papers)Heng Zhao (3 shared papers)Yongyu Liu (3 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)Annals of Oncology (2 papers)Bioactive Materials (1 paper)Complementary Therapies in Medicine (1 paper)Nano Letters (1 paper)
- Partner nations
- ChinaNetherlandsUnited States
In The Last Decade
Xiaofei Li
42 papers receiving 812 citations
Peers
Comparison fields: 5 of 76
- Pulmonary and Respiratory Medicine 374
- Oncology 243
- Cancer Research 111
- Gastroenterology 19
- Pathology and Forensic Medicine 46
Countries citing papers authored by Xiaofei Li
This map shows the geographic impact of Xiaofei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofei Li more than expected).
Fields of papers citing papers by Xiaofei Li
This network shows the impact of papers produced by Xiaofei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofei Li. The network helps show where Xiaofei Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaofei Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 183 | |
| 2 | 2017 | 58 | |
| 3 | 2020 | 44 | |
| 4 | 2018 | 44 | |
| 5 | 2022 | 43 | |
| 6 | 2015 | 33 | |
| 7 | 2012 | 32 | |
| 8 | 2024 | 29 | |
| 9 | 2006 | 27 | |
| 10 | 2016 | 24 | |
| 11 | Exendin-4, an analogue of glucagon-like peptide-1, attenuates hyperalgesia through serotonergic pathways in rats with neonatal colonic sensitivity. | 2014 | 23 |
| 12 | 2016 | 23 | |
| 13 | 2016 | 22 | |
| 14 | 2018 | 22 | |
| 15 | 2018 | 20 | |
| 16 | 2016 | 19 | |
| 17 | Robotic versus Laparoscopic Gastrectomy for Gastric Carcinoma: a Meta-Analysis of Efficacy and Safety. | 2016 | 17 |
| 18 | 2018 | 16 | |
| 19 | 2020 | 15 | |
| 20 | 2018 | 15 |
About Xiaofei Li
Xiaofei Li is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Cancer Research and Molecular Biology, having authored 44 papers that have together received 821 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (16 papers), Lung Cancer Research Studies (8 papers), Lung Cancer Diagnosis and Treatment (7 papers), Gastric Cancer Management and Outcomes (4 papers), Sarcoma Diagnosis and Treatment (2 papers), Lymphoma Diagnosis and Treatment (2 papers), Glycosylation and Glycoproteins Research (1 paper) and Osteoarthritis Treatment and Mechanisms (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (374 citations), Oncology (243 citations), Cancer Research (111 citations), Gastroenterology (19 citations) and Pathology and Forensic Medicine (46 citations). Xiaofei Li has collaborated with scholars based in China, Netherlands and United States. Frequent co-authors include Chun Chen, Weimin Mao, Lanjun Zhang, Yi Shen, Qun Wang, Dongsheng Yue, Heng Zhao, Yongyu Liu, Lidong Hu and Haitao Ma. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Bioactive Materials, Complementary Therapies in Medicine and Nano Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.